SG11201605757SA - Substituted amino triazoles, and methods using same - Google Patents
Substituted amino triazoles, and methods using sameInfo
- Publication number
- SG11201605757SA SG11201605757SA SG11201605757SA SG11201605757SA SG11201605757SA SG 11201605757S A SG11201605757S A SG 11201605757SA SG 11201605757S A SG11201605757S A SG 11201605757SA SG 11201605757S A SG11201605757S A SG 11201605757SA SG 11201605757S A SG11201605757S A SG 11201605757SA
- Authority
- SG
- Singapore
- Prior art keywords
- methods
- same
- substituted amino
- amino triazoles
- triazoles
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/14—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361919117P | 2013-12-20 | 2013-12-20 | |
PCT/US2014/071490 WO2015095701A1 (en) | 2013-12-20 | 2014-12-19 | Substituted amino triazoles, and methods using same |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201605757SA true SG11201605757SA (en) | 2016-08-30 |
Family
ID=53403739
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201605757SA SG11201605757SA (en) | 2013-12-20 | 2014-12-19 | Substituted amino triazoles, and methods using same |
Country Status (9)
Country | Link |
---|---|
US (1) | US10214531B2 (pl) |
EP (1) | EP3082805B1 (pl) |
JP (1) | JP2017501226A (pl) |
CN (1) | CN106659715A (pl) |
AU (1) | AU2014369053B2 (pl) |
CA (1) | CA2937147A1 (pl) |
PL (1) | PL3082805T3 (pl) |
SG (1) | SG11201605757SA (pl) |
WO (1) | WO2015095701A1 (pl) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106659697B (zh) * | 2014-05-30 | 2022-03-29 | 斯菲叶尔制药私有公司 | 作为抗结核剂的化合物 |
PL415073A1 (pl) * | 2014-12-19 | 2016-06-20 | Oncoarendi Therapeutics Spółka Z Ograniczoną Odpowiedzialnością | Podstawione aminotriazole przydatne jako inhibitory kwaśnej chitynazy ssaków |
WO2017021920A1 (en) * | 2015-08-05 | 2017-02-09 | Indivior Uk Limited | Dopamine d3 receptor antagonists having a bicyclo moiety |
PL415078A1 (pl) | 2015-09-04 | 2017-03-13 | Oncoarendi Therapeutics Spółka Z Ograniczoną Odpowiedzialnością | Podstawione aminotriazole przydatne jako inhibitory kwaśnej chitynazy ssaków |
KR20200043409A (ko) | 2017-08-21 | 2020-04-27 | 아카디아 파마슈티칼스 인코포레이티드 | 질병 치료를 위한 화합물, 이의 염 및 방법 |
US11440884B2 (en) * | 2017-08-21 | 2022-09-13 | Acadia Pharmaceuticals Inc. | Compounds, salts thereof and methods for treatment of diseases |
IL277071B1 (en) | 2018-03-08 | 2024-03-01 | Incyte Corp | Aminopyrizine diol compounds as PI3K–y inhibitors |
CN108467395B (zh) * | 2018-05-09 | 2020-12-11 | 大连理工大学 | 一种几丁质酶抑制剂及其应用 |
US11046658B2 (en) | 2018-07-02 | 2021-06-29 | Incyte Corporation | Aminopyrazine derivatives as PI3K-γ inhibitors |
BR112022000325A2 (pt) | 2019-07-11 | 2022-03-15 | Escape Bio Inc | Indazois e azaindazois como inibidores de lrrk2 |
CN114466845A (zh) * | 2019-09-25 | 2022-05-10 | 昂科艾伦迪治疗法公司 | 制备5-(4-((2s,5s)-5-(4-氯苄基)-2-甲基吗啉代)哌啶-1-基)-1h-1,2,4-三唑-3-胺的方法 |
US20230125481A1 (en) * | 2020-01-28 | 2023-04-27 | Evotec International Gmbh | Modulators of the integrated stress response pathway |
CN111732571B (zh) * | 2020-07-24 | 2021-06-29 | 广西壮族自治区农业科学院 | 一种用于防治香蕉枯萎病的杀植物真菌剂 |
CN114835687B (zh) * | 2021-04-02 | 2023-09-05 | 北京华森英诺生物科技有限公司 | AhR抑制剂 |
AU2022292554A1 (en) | 2021-06-14 | 2024-01-04 | Scorpion Therapeutics, Inc. | Urea derivatives which can be used to treat cancer |
US20230348516A1 (en) * | 2022-04-29 | 2023-11-02 | Molecure S.A. | Ykl-40 inhibitors and their therapeutic applications |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4421753A (en) * | 1982-01-15 | 1983-12-20 | American Cyanamid Company | 1-(5-Amino-4H-1,2,4-triazol-3-yl)-4-substituted-piperazines |
US4582833A (en) * | 1984-04-16 | 1986-04-15 | American Cyanamid Company | 2-(substituted-1-piperazinyl)[1,2,4]triazolo[1,5-a]pyrimidines |
GB0325745D0 (en) * | 2003-11-05 | 2003-12-10 | Astrazeneca Ab | Chemical compounds |
US8183241B2 (en) | 2005-06-01 | 2012-05-22 | Ucb Pharma, S.A. | 2-oxo-1-pyrrolidine derivatives |
WO2009082526A2 (en) | 2007-10-05 | 2009-07-02 | Pharmacopeia, Inc. | Ortho pyrrolidine, benzyl-substituted heterocycle ccr1 antagonists for autoimmune diseases & inflammation |
KR20140047032A (ko) | 2011-03-24 | 2014-04-21 | 얀센 파마슈티칼즈, 인코포레이티드 | 감마 세크레타제 조정제로서의 신규 치환 트리아졸릴 피페라진 및 트리아졸릴 피페리딘 유도체 |
-
2014
- 2014-12-19 SG SG11201605757SA patent/SG11201605757SA/en unknown
- 2014-12-19 US US15/037,090 patent/US10214531B2/en active Active
- 2014-12-19 CN CN201480076075.6A patent/CN106659715A/zh active Pending
- 2014-12-19 CA CA2937147A patent/CA2937147A1/en not_active Abandoned
- 2014-12-19 PL PL14871777T patent/PL3082805T3/pl unknown
- 2014-12-19 WO PCT/US2014/071490 patent/WO2015095701A1/en active Application Filing
- 2014-12-19 EP EP14871777.0A patent/EP3082805B1/en active Active
- 2014-12-19 AU AU2014369053A patent/AU2014369053B2/en active Active
- 2014-12-19 JP JP2016560862A patent/JP2017501226A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP3082805A1 (en) | 2016-10-26 |
WO2015095701A1 (en) | 2015-06-25 |
AU2014369053B2 (en) | 2019-03-14 |
JP2017501226A (ja) | 2017-01-12 |
CN106659715A (zh) | 2017-05-10 |
AU2014369053A1 (en) | 2016-07-28 |
PL3082805T3 (pl) | 2020-09-21 |
US20160297823A1 (en) | 2016-10-13 |
EP3082805B1 (en) | 2020-02-05 |
US10214531B2 (en) | 2019-02-26 |
EP3082805A4 (en) | 2017-05-10 |
CA2937147A1 (en) | 2015-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL276106A (en) | Garp-binding proteins and their uses | |
SG11201605757SA (en) | Substituted amino triazoles, and methods using same | |
GB201319878D0 (en) | Method, Array and use thereof | |
GB201306633D0 (en) | Biaising circuitry and method thereof | |
HK1198908A1 (en) | Beauty aid | |
EP3012292A4 (en) | TREATMENT ADJUVANT, AND COMPOSITION | |
IL240248A0 (en) | Met-binding substances and their uses | |
GB201312318D0 (en) | Novel methods and compounds | |
GB201300376D0 (en) | Method and compound | |
IL239762A0 (en) | Selective nox-1 blocking peptides and their use | |
ZA201507580B (en) | Urea mixtures and methods for making and using same | |
GB201308057D0 (en) | Protein | |
GB201313803D0 (en) | Fungicidal composition and method | |
ZA201600015B (en) | Anti-fibrogenic compounds, methods and uses thereof | |
SI3033532T1 (sl) | Vezni element, uporaba in postopek | |
GB201401955D0 (en) | Protein | |
ZA201601880B (en) | Hetero-transglycosylase and uses thereof | |
EP3015549A4 (en) | NOVEL POLYPEPTIDE AND USE THEREOF | |
GB201301640D0 (en) | Methods and peptides | |
GB201302031D0 (en) | Protein | |
GB201302030D0 (en) | Protein | |
GB201315295D0 (en) | Compound and method | |
GB201315289D0 (en) | Compound and method | |
GB201315291D0 (en) | Compound and method | |
GB201315292D0 (en) | Compound and method |